Symposia: Health Services and Quality—Lymphoid Malignancies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, adult, Clinical Practice (Health Services and Quality), Lymphomas, CLL, non-Hodgkin lymphoma, epidemiology, elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Combination therapy, Clinical Research, health outcomes research, health disparities research, Diseases, drug-drug interactions, Therapies, therapy sequence, real-world evidence, Adverse Events, Lymphoid Malignancies, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, adult, Clinical Practice (Health Services and Quality), Lymphomas, CLL, non-Hodgkin lymphoma, epidemiology, elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Combination therapy, Clinical Research, health outcomes research, health disparities research, Diseases, drug-drug interactions, Therapies, therapy sequence, real-world evidence, Adverse Events, Lymphoid Malignancies, Study Population, Human, Transplantation
Monday, December 12, 2022: 2:45 PM-4:15 PM
La Nouvelle Orleans Ballroom AB
(Ernest N. Morial Convention Center)
Moderators:
Ja Min Byun, MD, PhD, Seoul National University Hospital
and
Urshila Durani, MD, MPH, Mayo Clinic
Disclosures:
No relevant conflicts of interest to declare.
Moderators: Urshila Durani, Ja Min Byun
Back-up: Carla Casulo
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH